H35.712
Central serous chorioretinopathy, left eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Central serous chorioretinopathy (CSC) is an eye condition that affects the retina, leading to vision problems primarily in one eye. When it occurs in the left eye, it is classified under the ICD-10 code H35.712. This condition involves the buildup of fluid under the retina, which can cause visual distortion and blurriness. While it often resolves on its own, understanding its causes, symptoms, and treatment options can help manage the condition effectively.
Causes & Symptoms
Clinical Causes: Stress: Elevated stress levels are linked to CSC, possibly affecting hormone levels that influence fluid leakage Corticosteroid use: Both systemic and topical steroids have been associated with increased risk Hypertension: High blood pressure may contribute to the development of CSC Sleep disorders: Conditions like sleep apnea have been linked to ocular issues including CSC Genetic predisposition: Family history may increase susceptibility to the condition Type A personality: Individuals with competitive or urgent personalities may have a higher risk
Key Symptoms: Distorted vision or visual distortion Blurred central vision, making it difficult to read or see fine details Sometimes, a dark or gray spot appears in the central visual field Objects may appear smaller or larger than usual (metamorphopsia) Colors may seem less vibrant or faded In some cases, the affected eye may experience mild discomfort or a sensation of fullness
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive eye examination, including retinal imaging tests like optical coherence tomography (OCT) and fluorescein angiography. These tests help visualize fluid accumulation under the retina and rule out other eye conditions that could cause similar symptoms.
Treatment Protocols: While some cases of CSC resolve spontaneously over weeks to months, treatment options are available for persistent or recurrent cases: - Observation: Monitoring the condition for potential spontaneous resolution - Laser therapy: Focal laser treatment can seal leaks in the retinal pigment epithelium to prevent fluid accumulation - Photodynamic therapy (PDT): Uses a special light-activated medication to target abnormal blood vessels and reduce fluid leakage - Medications: Some drugs that affect fluid regulation or stress levels may be considered, though their use is still under research - Managing risk factors: Controlling stress, blood pressure, and avoiding corticosteroid medications when possible can help reduce recurrence risks
Clinical Advice & FAQs
Billing Guidance
Is H35.712 a billable ICD-10 code?
Yes, H35.712 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H35.712?
Clinical documentation must specify the nature of Central serous chorioretinopathy, left eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference